GC
ASPX

Guggenheim Capital’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Guggenheim Capital’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-11,727
Closed -$1.18M – 3172
2015
Q1 		$1.18M Buy
+11,727
New +$781K ﹤0.01% 2148

Guggenheim Capital's ASPX Position: Q2 2015 in Review

Guggenheim Capital sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 11,727 shares — an estimated $1.18M sold.

Guggenheim Capital first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $1.18M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Guggenheim Capital reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Guggenheim Capital sold 11,727 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.18M.
  • Guggenheim Capital first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Guggenheim Capital's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.18M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Guggenheim Capital's 13F filing for Q2 2015, filed 14 Aug 2015.